9-100284515-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_014425.5(INVS):āc.1980A>Gā(p.Gly660Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000414 in 1,614,098 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00022 ( 0 hom., cov: 33)
Exomes š: 0.00043 ( 5 hom. )
Consequence
INVS
NM_014425.5 synonymous
NM_014425.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.690
Genes affected
INVS (HGNC:17870): (inversin) This gene encodes a protein containing multiple ankyrin domains and two IQ calmodulin-binding domains. The encoded protein may function in renal tubular development and function, and in left-right axis determination. This protein interacts with nephrocystin and infers a connection between primary cilia function and left-right axis determination. A similar protein in mice interacts with calmodulin. Mutations in this gene have been associated with nephronophthisis type 2. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 9-100284515-A-G is Benign according to our data. Variant chr9-100284515-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 260408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-100284515-A-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.69 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000223 (34/152338) while in subpopulation SAS AF= 0.00684 (33/4828). AF 95% confidence interval is 0.005. There are 0 homozygotes in gnomad4. There are 25 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INVS | NM_014425.5 | c.1980A>G | p.Gly660Gly | synonymous_variant | 13/17 | ENST00000262457.7 | NP_055240.2 | |
INVS | NM_001318381.2 | c.1692A>G | p.Gly564Gly | synonymous_variant | 14/18 | NP_001305310.1 | ||
INVS | NM_001318382.2 | c.1002A>G | p.Gly334Gly | synonymous_variant | 13/17 | NP_001305311.1 | ||
INVS | NR_134606.2 | n.2178A>G | non_coding_transcript_exon_variant | 13/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INVS | ENST00000262457.7 | c.1980A>G | p.Gly660Gly | synonymous_variant | 13/17 | 1 | NM_014425.5 | ENSP00000262457.2 | ||
INVS | ENST00000262456.6 | c.1980A>G | p.Gly660Gly | synonymous_variant | 13/18 | 5 | ENSP00000262456.2 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152220Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
34
AN:
152220
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000983 AC: 246AN: 250374Hom.: 2 AF XY: 0.00136 AC XY: 184AN XY: 135626
GnomAD3 exomes
AF:
AC:
246
AN:
250374
Hom.:
AF XY:
AC XY:
184
AN XY:
135626
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000434 AC: 634AN: 1461760Hom.: 5 Cov.: 31 AF XY: 0.000635 AC XY: 462AN XY: 727194
GnomAD4 exome
AF:
AC:
634
AN:
1461760
Hom.:
Cov.:
31
AF XY:
AC XY:
462
AN XY:
727194
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000223 AC: 34AN: 152338Hom.: 0 Cov.: 33 AF XY: 0.000336 AC XY: 25AN XY: 74494
GnomAD4 genome
AF:
AC:
34
AN:
152338
Hom.:
Cov.:
33
AF XY:
AC XY:
25
AN XY:
74494
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
20
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 22, 2017 | - - |
Nephronophthisis Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at